• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • France

CM-CIC, Seventure in €23m Global Bioenergies capital increase

  • Amy King
  • 17 July 2013
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Industrial biology company Global Bioenergies, listed on the NYSE Alternext Paris, has raised €23m through the placement of 927,419 new shares.

The offer enjoyed a 143% subscription rate and could have ultimately raised €28.6m.

French GPs CM-CIC Capital and Seventure were joined by other European investors as well as backers in the US. 

Global Bioenergies

  • DEAL:

    PIPE

  • VALUE:

    €28.6m

  • LOCATION:

    Evry

  • SECTOR:

    Speciality chemicals

  • FOUNDED:

    2008

CM-CIC contributed €8.7m to the capital increase, according to French publication Capital Finance. The investor holds a combined stake of 11.65% across CM-CIC Investissement (7.34%), CM-CIC Capital Innovation (3.30%) and CM-CIC Capital Privé (1.01%). 

Existing backer Seventure is understood to have seen its stake in the firm diluted, despite contributing to the capital increase. The GP now holds a stake of 27.04%, making it the largest single shareholder in the company. 

The fresh capital will enable the firm to strengthen its industrial development through the construction of two pilots, and the launch of new programmes.

Gilbert Dupont and Oddo & Cie were lead arrangers and bookrunners on the transaction. 

Previous funding
In 2009, Global Bioenergies raised €3.2m from Seventure. The firm listed on the NYSE Alternext in Paris in 2011, raising €6.6m to support the development of its isobutene process. In the same year, the firm received a €2.7m capital injection from raw chemicals manufacturer Synthos. The French State committed €5.2m to the firm in 2013, as part of the Investissements d'Avenir programme.

Company
Founded in 2008 and based in Evry, Global Bioenergies is developing a process to convert renewable resources into hydrocarbons through fermentation.

The company initially focused on the production of isobutene, a petrochemical building block that can be converted into fuels, plastics, organic glass and elastomers. The company is now entering a phase of industrial pilot testing.

People
Karine Lignel is director of participations at CM-CIC Capital Innovation. Marc Delcourt is chief executive of Global Bioenergies.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • France
  • PIPEs
  • Industrials
  • France
  • CM-CIC Capital Finance
  • Seventure (SPEF)
  • Cleantech

More on France

EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
EU foreign subsidies regulations
EU FSR could impact PE fundraising with potential rise in ‘clean funds’

FSR could lead GPs to create funds without foreign LPs; red tape around sovereign wealth funds likely

  • Regulation
  • 01 September 2023
Mergermarket
Letter from the editor: Unquote is moving to Mergermarket

Unquote Editor Harriet Matthews outlines Unquote.com's upcoming move to the Mergermarket platform and the new capabilities and intelligence that this brings to Unquote readers

  • Industry
  • 30 August 2023
Pensions administration software providers
IK Investment-backed Eres expected to hit the auction block by 2024

French employee savings distribution and management firm could be valued at a few hundred million euros

  • Exits
  • 24 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013